Insider Selling: Oscar Health (NYSE:OSCR) Director Sells 150,000 Shares

Oscar Health, Inc. (NYSE:OSCR) Director Mario Schlosser sold 150,000 shares of the stock in a transaction dated Friday, August 28th. The stock was sold at an average price of $30.79, for a total transaction of $4,618,500.00. Following the transaction, the director owned 480,866 shares in the company, valued at approximately $14,805,864.14. The trade was a 23.78% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.

Mario Schlosser also recently made the following trade(s):

• On Thursday, August 27th, Mario Schlosser sold 600,000 shares of Oscar Health stock. The shares were sold at an average price of $30.34, for a total transaction of $18,204,000.00.
• On Tuesday, June 23rd, Mario Schlosser sold 147,500 shares of Oscar Health stock. The stock was sold at an average price of $29.38, for a total transaction of $4,333,550.00.
• On Tuesday, June 23rd, Mario Schlosser sold 880,000 shares of Oscar Health stock. The shares were sold at an average price of $29.38, for a total transaction of $25,854,400.00.
• On Tuesday, June 2nd, Mario Schlosser sold 34,120 shares of Oscar Health stock. The shares were sold at an average price of $21.94, for a total transaction of $748,592.80.

Oscar Health Stock Down 1.5%

NYSE:OSCR traded down $0.47 during trading hours on Monday, reaching $30.00. The company’s stock had a trading volume of 3,638,656 shares, compared to its average volume of 7,137,195. The company has a market capitalization of $9.26 billion, a P/E ratio of 21.43, a price-to-earnings-growth ratio of 0.63 and a beta of 2.36. Oscar Health, Inc. has a 12 month low of $10.69 and a 12 month high of $33.55. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.09 and a current ratio of 1.09. The stock has a 50 day moving average price of $30.27 and a two-hundred day moving average price of $22.13.

Oscar Health (NYSE:OSCR) last announced its earnings results on Thursday, August 6th. The company reported $1.10 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.40 by $0.70. Oscar Health had a return on equity of 38.45% and a net margin of 3.60%.The business had revenue of $4.88 billion for the quarter, compared to analysts’ expectations of $4.73 billion. During the same quarter last year, the firm earned ($0.89) EPS. The business’s revenue for the quarter was up 70.4% on a year-over-year basis. Equities analysts predict that Oscar Health, Inc. will post 1.54 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently weighed in on the company. Barclays raised their price objective on Oscar Health from $35.00 to $39.00 and gave the company an “overweight” rating in a research report on Thursday, August 6th. Wolfe Research began coverage on shares of Oscar Health in a report on Tuesday, May 5th. They issued a “peer perform” rating for the company. Robert W. Baird set a $27.00 price target on shares of Oscar Health in a research report on Friday, August 7th. UBS Group raised their price target on shares of Oscar Health from $20.00 to $26.00 and gave the company a “neutral” rating in a report on Friday, August 7th. Finally, Wall Street Zen raised shares of Oscar Health from a “buy” rating to a “strong-buy” rating in a research report on Sunday, June 14th. One analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and eight have assigned a Hold rating to the company. Based on data from MarketBeat.com, Oscar Health currently has a consensus rating of “Hold” and an average target price of $26.22.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in OSCR. GAMMA Investing LLC boosted its holdings in Oscar Health by 32.9% in the second quarter. GAMMA Investing LLC now owns 1,441 shares of the company’s stock worth $41,000 after acquiring an additional 357 shares in the last quarter. Focus Partners Wealth increased its holdings in shares of Oscar Health by 1.4% during the third quarter. Focus Partners Wealth now owns 57,787 shares of the company’s stock valued at $1,094,000 after acquiring an additional 824 shares in the last quarter. Equitable Holdings Inc. raised its position in shares of Oscar Health by 7.0% in the 4th quarter. Equitable Holdings Inc. now owns 12,975 shares of the company’s stock valued at $186,000 after purchasing an additional 850 shares during the last quarter. Captrust Financial Advisors raised its position in shares of Oscar Health by 2.0% in the 4th quarter. Captrust Financial Advisors now owns 45,754 shares of the company’s stock valued at $657,000 after purchasing an additional 895 shares during the last quarter. Finally, O Shaughnessy Asset Management LLC boosted its stake in Oscar Health by 5.6% in the 4th quarter. O Shaughnessy Asset Management LLC now owns 17,774 shares of the company’s stock worth $255,000 after purchasing an additional 938 shares in the last quarter. 75.70% of the stock is owned by institutional investors and hedge funds.

Oscar Health Company Profile

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.